Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer

Shuraila F. Zerp, Rianne Stoter, Frank J. P. Hoebers, Michiel W. M. van den Brekel, Ria Dubbelman, Gitta K. Kuipers, M. Vincent M. Lafleur, Ben J. Slotman, Marcel Verheij

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
Original languageEnglish
Article number158
JournalRadiation Oncology
Volume10
DOIs
Publication statusPublished - 30 Jul 2015

Keywords

  • Radiation
  • Head and neck cancer
  • Apoptosis
  • Bcl-2

Cite this

Zerp, S. F., Stoter, R., Hoebers, F. J. P., van den Brekel, M. W. M., Dubbelman, R., Kuipers, G. K., Lafleur, M. V. M., Slotman, B. J., & Verheij, M. (2015). Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer. Radiation Oncology, 10, [158]. https://doi.org/10.1186/s13014-015-0474-9